IGM Biosciences Inc reports results for the quarter ended in September - Earnings Summary

IGM Biosciences

04/11/2021 14:14

* IGM Biosciences Inc  IGMS.OQ  reported a quarterly adjusted
loss of $1.32​​ per share for the quarter ended in September.
The mean expectation of nine analysts for the quarter was for a
loss of $1.37 per share.
* Reported revenue was zero​;  analysts expected zero. 
* IGM Biosciences Inc's reported EPS for the quarter was a loss
of $1.32​.
* The mean earnings estimate of analysts had fallen by
about 2.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* IGM Biosciences Inc shares had fallen by 17.7% this
quarter and lost 38.7% so far this year.
* The company reported a quarterly loss of $44.16 million.
* Wall Street's median 12-month price target for IGM Biosciences
Inc is $101.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 4 at 02:14 p.m.
 ​All figures in US dollars unless otherwise stated